Antares Pharma reported $32.68M in Net Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2447M 458M
Abbvie ABBV:US $ 4490M 446M
Adma Biologics ADMA:US $ -25.01M 8.36M
Aerie Pharmaceuticals AERI:US $ -35.89M 81.42M
Ani Pharmaceuticals ANIP:US $ -20.13M 4.01M
Atrion ATRI:US 8.13M 150K
Becton, Dickinson and BDX:US $ 454M 223M
Cara Therapeutics CARA:US $ -27749000 5.63M
Cerus CERS:US $ -12.28M 3.16M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Horizon Pharma HZNP:US $ 204.26M 31.08M
Meridian Bioscience VIVO:US $ 28.75M 13.41M
Orasure Technologies OSUR:US $ -19.97M 9.57M
Pacira Pharmaceuticals PCRX:US $ 6.83M 11.96M
Pfizer PFE:US $ 7863M 4470M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Sientra SIEN:US $ -18.04M 1.97M
Staar Surgical STAA:US $ 9.6M 4.68M
Supernus Pharmaceuticals SUPN:US $ 25.62M 23.17M
Teva Pharmaceutical TEVA:IT -955000000 797M
Teva Pharmaceutical Industries TEVA:US $ -955M 797M
Utah Medical Products UTMD:US 4.21M 1.18M